160 related articles for article (PubMed ID: 36434144)
1. CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling.
Zhang X; Xu Q; Li E; Shi T; Chen H
Mol Cell Biochem; 2023 Jul; 478(7):1561-1571. PubMed ID: 36434144
[TBL] [Abstract][Full Text] [Related]
2. SMC4 knockdown inhibits malignant biological behaviors of endometrial cancer cells by regulation of FoxO1 activity.
Yan Y; Liu C; Zhang J; Li W; Yin X; Dong L; Pang S; Li X
Arch Biochem Biophys; 2021 Nov; 712():109026. PubMed ID: 34506757
[TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of roles of PPP1R14B in cervical and endometrial cancer.
Xiang N; Chen T; Zhao X; Zhao M
Tissue Cell; 2022 Aug; 77():101845. PubMed ID: 35679681
[TBL] [Abstract][Full Text] [Related]
4. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
5. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway.
Jiang J; Zhang C; Wang J; Zhu Y; Wang X; Mao P
Anticancer Agents Med Chem; 2023; 23(19):2127-2134. PubMed ID: 37670696
[TBL] [Abstract][Full Text] [Related]
8. Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness.
Peng T; Zhou W; Guo F; Wu HS; Wang CY; Wang L; Yang ZY
Sci Rep; 2017 Jul; 7(1):5925. PubMed ID: 28724890
[TBL] [Abstract][Full Text] [Related]
9. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
[TBL] [Abstract][Full Text] [Related]
10. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C
Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197
[TBL] [Abstract][Full Text] [Related]
11. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
[TBL] [Abstract][Full Text] [Related]
12. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
Yin Y; Cai J; Meng F; Sui C; Jiang Y
Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
[TBL] [Abstract][Full Text] [Related]
13. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J
Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735
[TBL] [Abstract][Full Text] [Related]
14. [MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1].
Yue Z; Shen JJ; Huang QT; Qin YF; Li XN; Liu GB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 May; 36(5):675-80. PubMed ID: 27222184
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
16. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
Myatt SS; Wang J; Monteiro LJ; Christian M; Ho KK; Fusi L; Dina RE; Brosens JJ; Ghaem-Maghami S; Lam EW
Cancer Res; 2010 Jan; 70(1):367-77. PubMed ID: 20028871
[TBL] [Abstract][Full Text] [Related]
17. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Potential of Long Noncoding RNA NEAT1 in Colorectal Cancer.
Cheng H; Malhotra A
J Environ Pathol Toxicol Oncol; 2020; 39(2):101-111. PubMed ID: 32749120
[TBL] [Abstract][Full Text] [Related]
19. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
Ward EC; Hoekstra AV; Blok LJ; Hanifi-Moghaddam P; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
Endocrinology; 2008 Apr; 149(4):1942-50. PubMed ID: 18096667
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
You B; Zhang KC
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
